Corrigendum to ‘‘Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model’’ [EBioMedicine 41 (2019) 465–478]

• Usha K. Nivarthi,
• Huy A. Tu,
• Matthew J. Delacruz,
• Jesica Swanstrom,
• Bhumi Patel,
• Anna P. Durbin,
• Stephen S. Whitehead,
• Kristen K. Pierce,
• Beth D. Kirkpatrick,
• Ralph S. Baric,
• Ngan Nguyen,
• Daniel E. Emerling,
• Aravinda M. de Silva,
• Sean A. Diehl

Affiliations

Usha K. Nivarthi

Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA

Huy A. Tu

Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA; Cellular, Molecular, and Biomedical Sciences Graduate Program, University of Vermont, Burlington, VT 05405, USA

Matthew J. Delacruz

Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA

Jesica Swanstrom

Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA

Bhumi Patel

Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA

Anna P. Durbin

Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA

Stephen S. Whitehead

Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, MD 20892, USA

Kristen K. Pierce

Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA

Beth D. Kirkpatrick

Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA

Ralph S. Baric

Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA

Ngan Nguyen

Atreca, Inc. Redwood City, California 94063, USA

Daniel E. Emerling

Atreca, Inc. Redwood City, California 94063, USA

Aravinda M. de Silva

Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Corresponding authors.

Sean A. Diehl

Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA; Corresponding authors.